tiprankstipranks
Advertisement
Advertisement

TSE:ABBV Stock Latest News

AbbVie presented new data across its gastroenterology portfolio at the 2026 DDW
The FlyAbbVie presented new data across its gastroenterology portfolio at the 2026 DDW
1d ago
ABBV
AbbVie price target raised to $236 from $232 at Evercore ISI
PremiumThe Fly
AbbVie price target raised to $236 from $232 at Evercore ISI
2d ago
ABBV
AbbVie: Hold Rating Reaffirmed as Skyrizi and Rinvoq Outperformance Potential Drives Price Target Increase to $244 Amid Ongoing Competitive and Pipeline Uncertainties
PremiumRatings
AbbVie: Hold Rating Reaffirmed as Skyrizi and Rinvoq Outperformance Potential Drives Price Target Increase to $244 Amid Ongoing Competitive and Pipeline Uncertainties
5d ago
ABBV
Midday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
PremiumThe Fly
Midday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
6d ago
UL
CAT
AbbVie price target raised to $278 from $270 at Morgan Stanley
PremiumThe Fly
AbbVie price target raised to $278 from $270 at Morgan Stanley
6d ago
ABBV
Meta downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
PremiumThe FlyMeta downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
6d ago
MG
RS
AbbVie price target raised to $265 from $262 at Canaccord
Premium
The Fly
AbbVie price target raised to $265 from $262 at Canaccord
6d ago
ABBV
AbbVie upgraded to Buy at BofA on durable growth
Premium
The Fly
AbbVie upgraded to Buy at BofA on durable growth
6d ago
ABBV
AbbVie upgraded to Buy from Neutral at BofA
PremiumThe Fly
AbbVie upgraded to Buy from Neutral at BofA
6d ago
ABBV
Midday Fly By: Seagate reports Q3 beat, Visa reports mixed Q2
PremiumThe Fly
Midday Fly By: Seagate reports Q3 beat, Visa reports mixed Q2
7d ago
V
BE
AbbVie raises FY26 revenue view to about $67.3B from about $67B
PremiumThe Fly
AbbVie raises FY26 revenue view to about $67.3B from about $67B
7d ago
ABBV
AbbVie sees Q2 adjusted EPS $3.74-$3.78, consensus $3.74
PremiumThe Fly
AbbVie sees Q2 adjusted EPS $3.74-$3.78, consensus $3.74
7d ago
ABBV
AbbVie sees FY26 adjusted gross margin ‘above 84% of sales’
PremiumThe FlyAbbVie sees FY26 adjusted gross margin ‘above 84% of sales’
7d ago
ABBV
Morning Movers: NXP Semi, Bloom Energy charged up after results
Premium
The Fly
Morning Movers: NXP Semi, Bloom Energy charged up after results
7d ago
BE
GD
AbbVie says ‘especially pleased’ with immunology and neuroscience results
Premium
The Fly
AbbVie says ‘especially pleased’ with immunology and neuroscience results
7d ago
ABBV
AbbVie reports Q1 adjusted EPS $2.65, consensus $2.67
PremiumThe Fly
AbbVie reports Q1 adjusted EPS $2.65, consensus $2.67
7d ago
ABBV
AbbVie raises FY26 adjusted EPS view to $14.08-$14.28 from $13.96-$14.16
PremiumThe Fly
AbbVie raises FY26 adjusted EPS view to $14.08-$14.28 from $13.96-$14.16
7d ago
ABBV
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
8d ago
GD
CAR
AbbVie submits application to FDA for new indication for upadacitinib
PremiumThe Fly
AbbVie submits application to FDA for new indication for upadacitinib
8d ago
ABBV
AbbVie submits application to FDA for Skyrizi for subcutaneous induction
PremiumThe FlyAbbVie submits application to FDA for Skyrizi for subcutaneous induction
9d ago
ABBV
AbbVie receives CRL from FDA regarding BLA for trenibotulinumtoxinE
Premium
The Fly
AbbVie receives CRL from FDA regarding BLA for trenibotulinumtoxinE
13d ago
ABBV
AbbVie price target lowered to $294 from $299 at Piper Sandler
Premium
The Fly
AbbVie price target lowered to $294 from $299 at Piper Sandler
13d ago
JNJ
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >